Search

Your search keyword '"Perin, Pc"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Perin, Pc" Remove constraint Author: "Perin, Pc" Search Limiters Full Text Remove constraint Search Limiters: Full Text
50 results on '"Perin, Pc"'

Search Results

1. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

2. Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

3. Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study

4. Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People

5. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

6. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

7. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia

8. Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial

9. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly

10. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

11. Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation

12. Gender-differences in disease distribution and outcome in hospitalized elderly: Data from the REPOSI study

13. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study

14. Correspondence between the international diabetes federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic caucasians: The GISIR database [4]

15. BLOOD-PRESSURE, RETINOPATHY AND URINARY ALBUMIN EXCRETION IN IDDM - THE EURODIAB IDDM COMPLICATIONS STUDY

16. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria

17. NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α.

18. C-reactive protein and 5-year survival in type 2 diabetes: the Casale Monferrato Study.

19. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy.

20. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study.

21. Electrocardiographic left ventricular hypertrophy in type 1 diabetes: prevalence and relation to coronary heart disease and cardiovascular risk factors: the Eurodiab IDDM Complications Study.

22. Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study

23. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database

24. Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes.

25. Hypoglycemia is independently associated with multidimensional impairment in elderly diabetic patients.

26. Urinary exosomal microRNAs in incipient diabetic nephropathy.

27. Prediction of mortality and macrovascular complications in type 2 diabetes: validation of the UKPDS Outcomes Model in the Casale Monferrato Survey, Italy.

28. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma.

29. Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study.

30. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.

31. An unusual dysphagia.

32. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

33. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient.

34. Stretch reduces nephrin expression via an angiotensin II-AT(1)-dependent mechanism in human podocytes: effect of rosiglitazone.

35. Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

36. Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study.

37. Heat shock protein expression in diabetic nephropathy.

38. The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes.

39. Dehydroepiandrosterone administration counteracts oxidative imbalance and advanced glycation end product formation in type 2 diabetic patients.

40. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation.

41. The MCP-1/CCR2 system has direct proinflammatory effects in human mesangial cells.

42. Primary and immortalised human pancreatic islet endothelial cells: phenotypic and immunological characterisation.

44. The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression.

45. Early referral of Type 2 diabetic patients: are we ready for the assault?

46. Prevalence of Q-T interval dispersion in type 1 diabetes and its relation with cardiac ischemia : the EURODIAB IDDM Complications Study Group.

47. Hypertensive rebound after angiotensin converting enzyme inhibitor withdrawal in diabetic patients with chronic renal failure.

48. A PC-1 amino acid variant (K121Q) is associated with faster progression of renal disease in patients with type 1 diabetes and albuminuria.

49. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.

50. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study.

Catalog

Books, media, physical & digital resources